ALHC Quote, Financials, Valuation and Earnings

Centene Corp. has a net margin of -1.09% compared to Alignment Healthcare, Inc.'s net margin of -2.21%. Alignment Healthcare, Inc.'s return on equity of -0.71% beat Centene Corp.'s return on equity of -27.11%.

Alignment Healthcare, Inc. has a consensus price target of $25.50, signalling upside risk potential of 38.21%. On the other hand Centene Corp. has an analysts' consensus of $44.35 which suggests that it could grow by 1.22%. Given that Alignment Healthcare, Inc. has higher upside potential than Centene Corp., analysts believe Alignment Healthcare, Inc. is more attractive than Centene Corp..

Alignment Healthcare, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.480, suggesting its less volatile than the S&P 500 by 51.962%.

Alignment Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare, Inc. pays -- of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend.

Alignment Healthcare, Inc. quarterly revenues are $1B, which are smaller than Centene Corp. quarterly revenues of $49.7B. Alignment Healthcare, Inc.'s net income of -$11M is higher than Centene Corp.'s net income of -$1.1B. Notably, Alignment Healthcare, Inc.'s price-to-earnings ratio is -- while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare, Inc. is 0.95x versus 0.11x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of -1.09% compared to Alignment Healthcare, Inc.'s net margin of -12.56%. Alignment Healthcare, Inc.'s return on equity of -0.71% beat Oscar Health, Inc.'s return on equity of -40.11%.

Alignment Healthcare, Inc. has a consensus price target of $25.50, signalling upside risk potential of 38.21%. On the other hand Oscar Health, Inc. has an analysts' consensus of $15.40 which suggests that it could grow by 12.66%. Given that Alignment Healthcare, Inc. has higher upside potential than Oscar Health, Inc., analysts believe Alignment Healthcare, Inc. is more attractive than Oscar Health, Inc..

Alignment Healthcare, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Alignment Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare, Inc. pays -- of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend.

Alignment Healthcare, Inc. quarterly revenues are $1B, which are smaller than Oscar Health, Inc. quarterly revenues of $2.8B. Alignment Healthcare, Inc.'s net income of -$11M is higher than Oscar Health, Inc.'s net income of -$352.4M. Notably, Alignment Healthcare, Inc.'s price-to-earnings ratio is -- while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare, Inc. is 0.95x versus 0.32x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Progyny, Inc. has a net margin of -1.09% compared to Alignment Healthcare, Inc.'s net margin of 3.92%. Alignment Healthcare, Inc.'s return on equity of -0.71% beat Progyny, Inc.'s return on equity of 11.8%.

Alignment Healthcare, Inc. has a consensus price target of $25.50, signalling upside risk potential of 38.21%. On the other hand Progyny, Inc. has an analysts' consensus of $29.64 which suggests that it could grow by 69.16%. Given that Progyny, Inc. has higher upside potential than Alignment Healthcare, Inc., analysts believe Progyny, Inc. is more attractive than Alignment Healthcare, Inc..

Alignment Healthcare, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.

Alignment Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare, Inc. pays -- of its earnings as a dividend. Progyny, Inc. pays out -- of its earnings as a dividend.

Alignment Healthcare, Inc. quarterly revenues are $1B, which are larger than Progyny, Inc. quarterly revenues of $318.4M. Alignment Healthcare, Inc.'s net income of -$11M is lower than Progyny, Inc.'s net income of $12.5M. Notably, Alignment Healthcare, Inc.'s price-to-earnings ratio is -- while Progyny, Inc.'s PE ratio is 26.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare, Inc. is 0.95x versus 1.22x for Progyny, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of -1.09% compared to Alignment Healthcare, Inc.'s net margin of 0.19%. Alignment Healthcare, Inc.'s return on equity of -0.71% beat UnitedHealth Group, Inc.'s return on equity of 12.31%.

Alignment Healthcare, Inc. has a consensus price target of $25.50, signalling upside risk potential of 38.21%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $364.63 which suggests that it could grow by 26.08%. Given that Alignment Healthcare, Inc. has higher upside potential than UnitedHealth Group, Inc., analysts believe Alignment Healthcare, Inc. is more attractive than UnitedHealth Group, Inc..

Alignment Healthcare, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.406, suggesting its less volatile than the S&P 500 by 59.394%.

Alignment Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group, Inc. offers a yield of 3.02% to investors and pays a quarterly dividend of $2.21 per share. Alignment Healthcare, Inc. pays -- of its earnings as a dividend. UnitedHealth Group, Inc. pays out 65.97% of its earnings as a dividend. UnitedHealth Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare, Inc. quarterly revenues are $1B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Alignment Healthcare, Inc.'s net income of -$11M is lower than UnitedHealth Group, Inc.'s net income of $218M. Notably, Alignment Healthcare, Inc.'s price-to-earnings ratio is -- while UnitedHealth Group, Inc.'s PE ratio is 21.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare, Inc. is 0.95x versus 0.59x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.